The Peptide Field
Menu

Sources · 208 listed

Sources behind the answers.

Find the sources behind these pages: drug labels, agency records, studies in people, and early studies in cells or animals. Each source shows which peptide reviews use it.

Narrow the list

Filters

Showing 61–80 of 208 sources

Source types explained

Official records and labels include agency records and product labels. Studies in people test a substance in people. Trial plans and status show planned or ongoing studies; they may not include results. Body changes in people covers studies of how a substance acts in people. Reviews and early studies cover research reviews and studies in cells or animals.

61
RegulatoryU.S. Food and Drug Administration · 2025Checked 2026-08-30

Forzinity FDA approval letter

Reviews using this sourceSS-31
Open source
62
Randomized trialPubMed · 2020Checked 2026-08-30

TAZPOWER randomized Barth syndrome study

Reviews using this sourceSS-31
Open source
63
Randomized trialPubMed · 2023Checked 2026-08-30

MMPOWER-3 phase 3 mitochondrial-myopathy study

Reviews using this sourceSS-31
Open source
64
Randomized trialPubMed · 2020Checked 2026-08-30

MMPOWER-2 mitochondrial-myopathy study

Reviews using this sourceSS-31
Open source
65
Randomized trialPubMed · 2020Checked 2026-08-30

PROGRESS-HF elamipretide heart-failure study

Reviews using this sourceSS-31
Open source
66
Human pilotPubMed · 2021Checked 2026-08-30

Elamipretide study in healthy older adults

Reviews using this sourceSS-31
Open source
67
Trial registryClinicalTrials.gov · 2017Checked 2026-08-30

TAZPOWER clinical study record

Reviews using this sourceSS-31
Open source
68
ReferenceU.S. Food and Drug Administration · 2026Checked 2026-08-30

FDA Global Substance Registration System record for Cerebrolysin

Reviews using this sourceCerebrolysin
Open source
69
RegulatoryU.S. Food and Drug Administration · 2026Checked 2026-08-30

FDA orphan drug designation explainer

Reviews using this sourceCerebrolysin
Open source
70
Drug labelAustrian Federal Office for Safety in Health Care (BASG) · 2021Checked 2026-08-30

Cerebrolysin Austrian product information

Reviews using this sourceCerebrolysin
Open source
71
Randomized trialPubMed · Stroke · 2012Checked 2026-08-30

CASTA randomized acute stroke trial

Reviews using this sourceCerebrolysin
Open source
72
Trial registryClinicalTrials.gov · 2009Checked 2026-08-30

CASTA trial record (NCT00868283)

Reviews using this sourceCerebrolysin
Open source
73
Science reviewPubMed · Cochrane Database of Systematic Reviews · 2023Checked 2026-08-30

Cochrane review of Cerebrolysin for acute ischemic stroke

Reviews using this sourceCerebrolysin
Open source
74
Science reviewPubMed · Cochrane Database of Systematic Reviews · 2019Checked 2026-08-30

Cochrane review of Cerebrolysin for vascular dementia

Reviews using this sourceCerebrolysin
Open source
75
Randomized trialPubMed · Journal of Neural Transmission · 2002Checked 2026-08-30

Randomized Cerebrolysin study in Alzheimer's disease

Reviews using this sourceCerebrolysin
Open source
76
ReferencePubMed · Drug Testing and Analysis · 2015Checked 2026-08-30

Peptide profile of an Internet-obtained Cerebrolysin sample

Reviews using this sourceCerebrolysin
Open source
77
ReferencePubMed · Journal of Medical Life · 2024Checked 2026-08-30

Comparison of Cerebrolysin with other peptide preparations

Reviews using this sourceCerebrolysin
Open source
78
FDA reviewU.S. Food and Drug Administration · 2024Checked 2026-08-30

FDA review of Kisspeptin-10 for pharmacy compounding

Reviews using this sourceKisspeptin-10
Open source
79
ReferenceU.S. Food and Drug Administration · 2026Checked 2026-08-30

FDA substance identity record for Kisspeptin-10

Reviews using this sourceKisspeptin-10
Open source
80
Human pharmacologyPubMed · Journal of Clinical Endocrinology and Metabolism · 2011Checked 2026-08-30

Kisspeptin-10 and reproductive hormone release in healthy men

Reviews using this sourceKisspeptin-10
Open source

About this list

How this list works

This list includes sources used in the peptide reviews. Each source appears once, followed by the reviews that use it. Guide citations stay on their guide pages. A source here may support some claims, not every claim, about a peptide.